Back to School: How biopharma can reboot drug development. Access exclusive analysis here
Biocon (NSE:BIOCONEQ) reported an operating profit of Rs. 486 million
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury